Dextromethorphan Hydrobromide/Promethazine Hydrochloride: a H1 receptor antagonists, NMDA receptor antagonists Drug, Initially developed by ANI
Acetaminophen/Amantadine/Loratadine: a COX inhibitors, DRDs agonists, H1 receptor antagonists, NMDA receptor antagonists Drug, Initially developed by
Relmada's lead program, dextromethadone (REL-1017), is an N-methyl-D-aspartate (NMDA) receptor antagonist. NMDA receptor antagonists may have
Magnesium's painkilling effects and tolerance reducing effects come from its effects as an NMDA receptor antagonist. DXM and other NMDA receptor antagonists have the same effects.
The discovery of glycine as a coagonist of NMDA receptors has led to intensive research of glycine/NMDA antagonists as potential CNS drugs. The robust efficacy of glycine/NMDA antagonists, such as ACEA-1021 (5), in animal model of brain ischemia, together with good safety profile in animal models and in clinical trials, suggested that this
A NMDA receptor antagonist used for treatment-resistant depression. Drugs Drug Targets. Drug, Target, Type. Esketamine NMDA receptor, target.
Given the dual antidepressant and anti-dyskinetic effects of ketamine and other N-methyl-D-aspartate (NMDA) antagonists for PD, this review aims to examine the current evidence of NMDA antagonists
by A Pribish 2024 Cited by 77As a nonselective NMDA receptor antagonist, it has equal affinity for different NMDA receptor types. NMDA is a subgroup of ionotropic glutamate
by B Revol 2024 Cited by 3addictovigilance, dependence, drug abuse, NMDA-R antagonists, VigiBase NMDA receptor antagonists and pain relief: a meta-analysis of
Comments